Literature DB >> 12620289

The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases.

Takuya Fukushima1, Yasushi Miyazaki, Hideki Tsushima, Chizuko Tsutsumi, Jun Taguchi, Shinichiro Yoshida, Kazutaka Kuriyama, David Scadden, Stephen Nimer, Masao Tomonaga.   

Abstract

ETS proteins (such as PU.1, Fli-1 and ETS-1) have been shown to play important roles in normal and abnormal hematopoiesis. We examined the expression of the ELF subfamily of ETS genes (ELF-1, MEF and NERF) in acute myeloid leukemia (AML) cells using Northern blot analysis. ELF-1 and MEF were expressed in all samples, whereas NERF was not. The relative expression (RE) of MEF, but not ELF-1, was significantly lower (P<0.0001) in AML with t(8;21) and t(15;17) compared with AML with normal karyotype. The pattern of MEF expression was not uniform among cells with CD34(+)/CD33(+). It is suggested that the low RE of MEF might be part of a gene expression profile characterizing AML with a good prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620289     DOI: 10.1016/s0145-2126(02)00214-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  Mechanisms of self-renewal in hematopoietic stem cells.

Authors:  Zhao Wang; Hideo Ema
Journal:  Int J Hematol       Date:  2015-12-12       Impact factor: 2.490

Review 2.  The oncogenic role of the ETS transcription factors MEF and ERG.

Authors:  Goro Sashida; Elena Bazzoli; Silvia Menendez; Yan Liu; Stephen D Nimer
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

3.  Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.

Authors:  Ping Xiang; Chaoyu Lo; Bob Argiropoulos; C Benjamin Lai; Arefeh Rouhi; Suzan Imren; Xiaoyan Jiang; Dixie Mager; R Keith Humphries
Journal:  Exp Hematol       Date:  2010-06-23       Impact factor: 3.084

4.  ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.

Authors:  Goro Sashida; Yan Liu; Shannon Elf; Yasuhiko Miyata; Kazuma Ohyashiki; Miki Izumi; Silvia Menendez; Stephen D Nimer
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

5.  MEF promotes stemness in the pathogenesis of gliomas.

Authors:  Elena Bazzoli; Teodoro Pulvirenti; Moritz C Oberstadt; Fabiana Perna; Boyoung Wee; Nikolaus Schultz; Jason T Huse; Elena I Fomchenko; Francesca Voza; Viviane Tabar; Cameron W Brennan; Lisa M DeAngelis; Stephen D Nimer; Eric C Holland; Massimo Squatrito
Journal:  Cell Stem Cell       Date:  2012-12-07       Impact factor: 24.633

Review 6.  Leukemia and hematopoietic stem cells: balancing proliferation and quiescence.

Authors:  Craig D Jude; Justin J Gaudet; Nancy A Speck; Patricia Ernst
Journal:  Cell Cycle       Date:  2008-01-01       Impact factor: 4.534

7.  Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.

Authors:  Koji Ando; Hideki Tsushima; Emi Matsuo; Kensuke Horio; Shinya Tominaga-Sato; Daisuke Imanishi; Yoshitaka Imaizumi; Masako Iwanaga; Hidehiro Itonaga; Shinichiro Yoshida; Tomoko Hata; Ryozo Moriuchi; Hitoshi Kiyoi; Stephen Nimer; Hiroyuki Mano; Tomoki Naoe; Masao Tomonaga; Yasushi Miyazaki
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

8.  Integration of Elf-4 into stem/progenitor and erythroid regulatory networks through locus-wide chromatin studies coupled with in vivo functional validation.

Authors:  Aileen M Smith; Fernando J Calero-Nieto; Judith Schütte; Sarah Kinston; Richard T Timms; Nicola K Wilson; Rebecca L Hannah; Josette-Renee Landry; Berthold Göttgens
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

Review 9.  Roles and regulations of the ETS transcription factor ELF4/MEF.

Authors:  Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Mol Cell Biol       Date:  2017-06-01       Impact factor: 6.216

10.  STARD4 promotes breast cancer cell malignancy.

Authors:  Min Zhang; Zhen Xiang; Feng Wang; Rong Shan; Ling Li; Juan Chen; Bao-An Liu; Juan Huang; Lun-Quan Sun; Wei-Bing Zhou
Journal:  Oncol Rep       Date:  2020-10-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.